Clinical Trial Update: Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate-to-Severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of D-2570 in adults with moderate-to-severe plaque psoriasis; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• D-2570

Snippet

Sponsor: InventisBio Co., Ltd | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED